Legacy Advisors, LLC Compugen LTD Transaction History
Legacy Advisors, LLC
- $683 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding CGEN
# of Institutions
78Shares Held
13.7MCall Options Held
15.2KPut Options Held
41.3K-
Silverarc Capital Management, LLC3.31MShares$5.56 Million0.98% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.41MShares$2.36 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.06MShares$1.78 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.71 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC965KShares$1.62 Million0.73% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $146M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...